Spots Global Cancer Trial Database for psa
Every month we try and update this database with for psa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients | NCT02091531 | Metastatic Cast... | MLN0128 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer | NCT04692675 | Prostate Cancer | mpMRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Prostate Impendance Test Project | NCT03428087 | Prostatic Neopl... PSA Prostatic Biops... Impedance Test | 45 Years - | University of Pisa | ||
| Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate Cancer | NCT03023345 | Low-Risk Prosta... | Microwave trans... | 45 Years - 76 Years | Assistance Publique - Hôpitaux de Paris | |
| Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00323882 | Prostate Cancer Neoplasm Metast... | MDX-010 | 18 Years - | Bristol-Myers Squibb | |
| Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer | NCT02514213 | Prostate Cancer | 2mg INO-5150 an... 8.5mg INO-5150 ... 2mg INO-5150 pl... 8.5mg INO-5150 ... Electroporation... | 18 Years - 90 Years | Inovio Pharmaceuticals | |
| Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test | NCT05629494 | Prostate Cancer Prostate Inflam... PSA | Ibuprofen or Na... PSA test | 18 Years - 80 Years | Albany Medical College | |
| Influence of Selenium on Prostate Cancer Related Biomarkers | NCT01112449 | Effect of Selen... | Placebo selenomethionin... low dose seleni... high dose selen... | 20 Years - 79 Years | Milton S. Hershey Medical Center | |
| Smart Prostate Specific Antigen (PSA) Screening Study | NCT04782713 | PSA Prostate Cancer | Completing surv... | 18 Years - | University of Illinois at Chicago | |
| Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | NCT02070575 | Prostate Cancer | blood draw | 30 Years - | Memorial Sloan Kettering Cancer Center | |
| Prostvac in Patients With Biochemically Recurrent Prostate Cancer | NCT02649439 | Prostate Cancer | PROSTVAC -V PROSTVAC-F | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| MRI and Biomarkers in Prostate Cancer | NCT02241122 | Prostate Cancer | prostate biopsy | 18 Years - 85 Years | Turku University Hospital | |
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA | NCT04319783 | Advanced Prosta... Cancer of Prost... PSA Castrate Resist... | Darolutamide Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | NCT00108290 | Prostate Cancer | Chemotherapy | 18 Years - 80 Years | VA Office of Research and Development | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | NCT00861471 | Prostate Cancer Prostatic Neopl... | Docetaxel Imatinib Mesyla... | 18 Years - | NYU Langone Health | |
| PROvenge Treatment and Early Cancer Treatment | NCT00779402 | Prostate Cancer | Control Sipuleucel-T | 18 Years - 80 Years | Dendreon | |
| Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer | NCT02198859 | Prostate Cancer | Lithium Carbona... | 18 Years - | University of Kansas Medical Center | |
| Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer | NCT02514213 | Prostate Cancer | 2mg INO-5150 an... 8.5mg INO-5150 ... 2mg INO-5150 pl... 8.5mg INO-5150 ... Electroporation... | 18 Years - 90 Years | Inovio Pharmaceuticals | |
| Marker Driven Selection of Patients for Prostate Biopsy and Management | NCT04240327 | PSA Elevated PSA Prostate Cancer | 40 Years - 85 Years | University of Miami | ||
| CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) | NCT01206036 | Prostatic Neopl... | Docetaxel Temsirolimus | 18 Years - | Central European Society for Anticancer Drug Research | |
| Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial | NCT02391051 | Prostate Cancer | HDR-Brachythera... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications | NCT04081636 | Prostate Cancer PSA Infection | Systematic Tran... Targeted Transr... Systematic Tran... Targeted Transp... | - | Albany Medical College | |
| Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer | NCT00731848 | Prostate Cancer | pomegranate liq... | 18 Years - | Roll International Corporation | |
| Prostate Cancer Screening: a Pilot Study | NCT06238661 | Prostate Cancer | Urology visit w... | 55 Years - 65 Years | Fondazione del Piemonte per l'Oncologia | |
| Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance | NCT03495479 | Prostate Cancer | OMN54 | 18 Years - 72 Years | Omnitura Therapeutics, Inc. | |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | NCT00878436 | Prostate Cancer Prostatic Neopl... | Panobinostat Bicalutamide | 18 Years - | NYU Langone Health | |
| Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer | NCT02796898 | Prostate Cancer Rising Prostate... | SM88 (Cohort 1) SM88 (Cohort 2) | 18 Years - | Tyme, Inc | |
| Prostvac in Patients With Biochemically Recurrent Prostate Cancer | NCT02649439 | Prostate Cancer | PROSTVAC -V PROSTVAC-F | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer | NCT00859729 | Prostate Cancer | pVAXrcPSAv53l (... DERMA VAX™ intr... | 18 Years - | Uppsala University | |
| Influence of Selenium on Prostate Cancer Related Biomarkers | NCT01112449 | Effect of Selen... | Placebo selenomethionin... low dose seleni... high dose selen... | 20 Years - 79 Years | Milton S. Hershey Medical Center | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females | NCT03436745 | Prostatic Neopl... | Zolpidem | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk | NCT00056407 | Neoplasms, Pros... | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients | NCT00433797 | Prostate Cancer | Prostate cancer... | - | University of Oslo | |
| PSA Glycomics Assay for Early Detection of Prostate Cancer | NCT04393376 | Prostate Cancer PSA | PSA Glycomics A... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer | NCT04067570 | SBRT Radical Prostat... | SBRT | - | Sunnybrook Health Sciences Centre | |
| Multimodality Phase II Study in Prostate Cancer | NCT00734851 | Prostate Cancer | Docetaxel Sunitinib EBXRT | 18 Years - | Duke University | |
| Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer | NCT04067570 | SBRT Radical Prostat... | SBRT | - | Sunnybrook Health Sciences Centre | |
| PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment | NCT00694551 | Prostate Cancer | Peptide Vaccine Poly IC-LC | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| TKI258 in Castrate Resistant Prostate Cancer | NCT00831792 | Prostate Cancer | TK1258 | - | M.D. Anderson Cancer Center | |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | NCT00878436 | Prostate Cancer Prostatic Neopl... | Panobinostat Bicalutamide | 18 Years - | NYU Langone Health | |
| ReIMAGINE Prostate Cancer Screening | NCT04063566 | Prostate Cancer... Prostate Cancer | Magnetic Resona... Prostate-specif... | 50 Years - 75 Years | University College, London | |
| Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy | NCT05295407 | Prostate Cancer | Genetic Assessm... | 40 Years - 69 Years | NorthShore University HealthSystem | |
| TKI258 in Castrate Resistant Prostate Cancer | NCT00831792 | Prostate Cancer | TK1258 | - | M.D. Anderson Cancer Center | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | NCT05025527 | Prostate Cancer | biparametric MR... Prostate cancer... | 50 Years - 80 Years | Shanghai East Hospital | |
| Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer | NCT00859729 | Prostate Cancer | pVAXrcPSAv53l (... DERMA VAX™ intr... | 18 Years - | Uppsala University | |
| Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide | NCT00871585 | Advanced Prosta... | 40 Years - | AstraZeneca | ||
| Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer | NCT00732043 | Prostate Cancer | pomegranate ext... pomegranate jui... placebo | 18 Years - | Roll International Corporation | |
| MRI and Biomarkers in Prostate Cancer | NCT02241122 | Prostate Cancer | prostate biopsy | 18 Years - 85 Years | Turku University Hospital | |
| CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) | NCT01206036 | Prostatic Neopl... | Docetaxel Temsirolimus | 18 Years - | Central European Society for Anticancer Drug Research | |
| Prostate Cancer Screening With Abbreviated MRI Protocol | NCT05603351 | Prostate Cancer | magnetic resona... serum PSA exami... Biopsy | 50 Years - 69 Years | Masaryk Memorial Cancer Institute | |
| Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications | NCT04081636 | Prostate Cancer PSA Infection | Systematic Tran... Targeted Transr... Systematic Tran... Targeted Transp... | - | Albany Medical College | |
| Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy | NCT00895310 | Prostate Cancer | Ketoconazole Hydrocortisone | 18 Years - | University of California, Davis | |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | NCT05622162 | Prostate Cancer 18F- Fluorochol... PSMA PET Radiotherapy Prostatectomy Tumor of Prosta... | Radiopharmaceut... Radiopharmaceut... | 18 Years - | ITEL Telecomunicazioni Srl | |
| Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment | NCT03531827 | Metastatic Cast... Prostate Neopla... | enzalutamide CRLX101 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Radium-223 in Biochemically Recurrent Prostate Cancer | NCT04206319 | Biochemical Rec... | Radium-223 18F Sodium Fluo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy. | NCT04858880 | Prostate Cancer | Radiation to th... | 18 Years - | Lund University Hospital | |
| Smart Prostate Specific Antigen (PSA) Screening Study | NCT04782713 | PSA Prostate Cancer | Completing surv... | 18 Years - | University of Illinois at Chicago | |
| Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy. | NCT04858880 | Prostate Cancer | Radiation to th... | 18 Years - | Lund University Hospital | |
| MRI/Ultrasound Fusion Guided Prostate Cryotherapy | NCT02381990 | Neoplasms Prost... Cancer of the P... | FUSE IMAGE MRI ... | 55 Years - | Urological Research Network, LLC | |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer | NCT01171729 | Prostatic Cance... | Autologous dend... | 18 Years - | Samsung Medical Center | |
| Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies. | NCT02050542 | Prostate Cancer | systematic biop... Targeted biopsi... | 45 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | NCT03315871 | Prostate Cancer | PROSTVAC-V PROSTVAC-F MSB0011359C (M7... CV301 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Metformin With Simvastatin for Men With Prostate Carcinoma | NCT01561482 | Prostate Carcin... | Metformin Simvastatin | 18 Years - | Baylor College of Medicine | |
| Open Label Trial to Assess Iressa in Prostate Cancer Patients | NCT00635856 | Prostate Cancer | Gefitinib | 18 Years - | AstraZeneca | |
| Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer | NCT04808427 | Prostate Cancer | TULSA-PRO | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | NCT00065442 | Prostate Cancer | Sipuleucel-T APC-Placebo | 18 Years - | Dendreon | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Automatic Detection in MRI of Prostate Cancer: DAICAP | NCT05513820 | Detection and C... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | NCT00861471 | Prostate Cancer Prostatic Neopl... | Docetaxel Imatinib Mesyla... | 18 Years - | NYU Langone Health | |
| Effect of Lap-Band Induced Weight Loss on Serum PSA Levels | NCT00562341 | Obesity Prostate Cancer | Bariatric Surge... | 20 Years - 60 Years | Maimonides Medical Center | |
| MRI and Biomarkers in Prostate Cancer | NCT02241122 | Prostate Cancer | prostate biopsy | 18 Years - 85 Years | Turku University Hospital | |
| Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer | NCT01171729 | Prostatic Cance... | Autologous dend... | 18 Years - | Samsung Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
